Literature DB >> 26571447

Rectal Carcinoma on 68Ga-PSMA PET/CT.

Yi-Tung Tom Huang1, William Fong, Paul Thomas.   

Abstract

We report on a case of biopsy-proven and MRI-staged rectal carcinoma with avid prostate-specific membrane antigen (prostate-specific membrane antigen) uptake on Ga PET/CT as part of the workup for synchronous prostate cancer. This case adds to the growing number of observational reports on the presence of significant nonprostatic prostate-specific membrane antigen activity in malignant tumors and highlights the need for careful interpretation of unsuspected sites.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26571447     DOI： 10.1097/RLU.0000000000001072

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  11 in total

1.  68Ga-Prostate-Specific Membrane Antigen, A Potential Radiopharmaceutical in PET/CT To detect primary Cholangiocarcinoma.

Authors:  Rita Chahinian; Ahmad El-Amine; Sayed Matar; Mostafa Annan; Ali Shamseddine; Mohamad Haidar
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020

2.  Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen-Targeted PET Imaging: PSMA-RADS Version 1.0.

Authors:  Steven P Rowe; Kenneth J Pienta; Martin G Pomper; Michael A Gorin
Journal:  J Nucl Med       Date:  2017-09-08       Impact factor: 10.057

3.  [68Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.

Authors:  Frédéric Bois; Camille Noirot; Sébastien Dietemann; Ismini C Mainta; Thomas Zilli; Valentina Garibotto; Martin A Walter
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

Review 4.  Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.

Authors:  Steven P Rowe; Alexander Drzezga; Bernd Neumaier; Markus Dietlein; Michael A Gorin; Michael R Zalutsky; Martin G Pomper
Journal:  J Nucl Med       Date:  2016-10       Impact factor: 10.057

Review 5.  Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.

Authors:  Philipp Backhaus; Benjamin Noto; Nemanja Avramovic; Lena Sophie Grubert; Sebastian Huss; Martin Bögemann; Lars Stegger; Matthias Weckesser; Michael Schäfers; Kambiz Rahbar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-01-15       Impact factor: 9.236

Review 6.  Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Authors:  Sara Sheikhbahaei; Ali Afshar-Oromieh; Matthias Eiber; Lilja B Solnes; Mehrbod S Javadi; Ashley E Ross; Kenneth J Pienta; Mohamad E Allaf; Uwe Haberkorn; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-01       Impact factor: 9.236

7.  Incidental prostate-specific membrane antigen-avid glioblastoma detected on 68Ga-prostate-specific membrane antigen PET/CT.

Authors:  James Yuheng Jiang; Christine Kang; Paul Bui; Robert Mansberg
Journal:  Radiol Case Rep       Date:  2022-04-08

8.  Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block.

Authors:  Ansje S Fortuin; Roger Brüggemann; Janine van der Linden; Ilia Panfilov; Bas Israël; Tom W J Scheenen; Jelle O Barentsz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-04-06

9.  PSMA Expression in Multinodular Thyroid Neoplasm on Simultaneous Ga-68-PSMA PET/MRI.

Authors:  Amarnath Jena; Shuaib Zaidi; Vikas Kashyap; Abhishek Jha; Sangeeta Taneja
Journal:  Indian J Nucl Med       Date:  2017 Apr-Jun

10.  Demonstration of 68Ga-prostate-specific Membrane Antigen Uptake in Metastatic Pancreatic Neuroendocrine Tumor.

Authors:  Meghana Prabhu; Nishikant Avinash Damle; Ravikant Gupta; Saurabh Arora; Sreedharan Thankarajan Arunraj; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.